Rapidly progressive erosions and ulcerations in a patient with cancer-associated anti-TIF-1γ/α and anti-U1 RNP-positive dermatomyositis: A case report

被引:1
|
作者
Rosseels, W. [1 ,2 ]
Vulsteke, J. B. [1 ,2 ]
Bosisio, F. [3 ]
Satoh, M. [4 ]
De Langhe, E. [1 ,2 ,5 ]
De Haes, P. [2 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Leuven, Div Rheumatol, Leuven, Belgium
[2] European Reference Network Rare & Complex Connect, Leuven, Belgium
[3] Univ Hosp Leuven, Div Pathol, Leuven, Belgium
[4] Univ Occupat & Environm Hlth, Sch Hlth Sci, Dept Clin Nursing, Fukuoka, Japan
[5] Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Tissue Homeostasis & Dis, Leuven, Belgium
[6] Univ Hosp Leuven, Div Dermatol, Leuven, Belgium
[7] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium
[8] UZ Leuven, Div Dermatol, Herestr 49, B-3000 Leuven, Belgium
关键词
PROTEIN;
D O I
10.1111/jdv.19339
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E1403 / E1404
页数:2
相关论文
共 50 条
  • [41] EFFECTIVE IMMUNOTHERAPY OF ANTI-TIF1-GAMMA-POSITIVE PARANEOPLASTIC DERMATOMYOSITIS WITH CONCURRENT DIAGNOSIS OF OVARIAN CANCER
    Jazebi, Noushin
    Shanina, Elena
    MUSCLE & NERVE, 2019, 60 : S71 - S71
  • [42] Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis
    Omagari, K
    Matsuo, I
    Ohba, K
    Masuda, J
    Hazama, H
    Sakimura, K
    Kinoshita, H
    Tsurutani, H
    Isomoto, H
    Murase, K
    Kohno, S
    HEPATOLOGY RESEARCH, 2001, 19 (03) : 263 - 269
  • [43] Anti-MDA5 Antibody-associated Juvenile Dermatomyositis and Rapidly Progressive ILD: A Pediatric Case Report
    Escobar, N. S.
    Verma, R.
    Bonilla, L. Garcia
    Kritzinger, F. E.
    Mastrangelo, G.
    Limenis, E.
    Mtaweh, H.
    Mema, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [44] Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab
    Palermo, B. L.
    Bottazzi, F.
    Dourado, E.
    Codullo, V
    Civardi, L.
    Zanframundo, G.
    Cavagna, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (05) : S118 - S120
  • [45] Cutaneous ulceration in dermatomyositis. Case reports with positive anti-NXP-2/anti-TIF1-gamma antibody status
    Wald, Caroline
    Simon, Jan-Christoph
    Treudler, Regina
    DERMATOLOGIE, 2025, 76 (02): : 97 - 100
  • [46] Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
    Qiu, Yulu
    Feng, Xiaoke
    Liu, Chang
    Shi, Yumeng
    Xu, Lingxiao
    You, Hanxiao
    Wang, Lei
    Lv, Chengyin
    Wang, Fang
    Tan, Wenfeng
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [47] Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
    Tomita, Natsuo
    Tamechika, Shin-Ya
    Kawakita, Daisuke
    Saito, Kenta
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
  • [48] Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
    Yulu Qiu
    Xiaoke Feng
    Chang Liu
    Yumeng Shi
    Lingxiao Xu
    Hanxiao You
    Lei Wang
    Chengyin Lv
    Fang Wang
    Wenfeng Tan
    Arthritis Research & Therapy, 26
  • [49] Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis
    Li, Xiaomeng
    Huang, Yuan
    Liu, Yongmei
    Yan, Songxin
    Li, Liubing
    Cheng, Linlin
    Li, Haolong
    Zhan, Haoting
    Zhang, Fengchun
    Li, Yongzhe
    CLINICAL RHEUMATOLOGY, 2023, 42 (03) : 817 - 830
  • [50] Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis
    Xiaomeng Li
    Yuan Huang
    Yongmei Liu
    Songxin Yan
    Liubing Li
    Linlin Cheng
    Haolong Li
    Haoting Zhan
    Fengchun Zhang
    Yongzhe Li
    Clinical Rheumatology, 2023, 42 : 817 - 830